We are live on ! Find out more
PCM

Piermont Capital Management Portfolio holdings

AUM $211M
1-Year Est. Return 8.09%
This Fund
S&P 500
This Quarter Est. Return
+3.97%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
AUM
$305M
AUM Growth
+$2.79M
Cap. Flow
-$5.16M
Cap. Flow %
-1.69%
Top 10 Hldgs %
10.9%
Holding
274
New
32
Increased
28
Reduced
121
Closed
37

Sector Composition

Rank Sector Weight
1 Financials 22.99%
2 Industrials 16.84%
3 Consumer Discretionary 11.25%
4 Technology 10.67%
5 Real Estate 10.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNSL
226
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$237K 0.08%
19,450
-1,086
-5% -$17.1K
IPGP icon
227
IPG Photonics
IPGP
$3.69B
$229K 0.08%
+1,070
New +$227K
VNDA icon
228
Vanda Pharmaceuticals
VNDA
$308M
$224K 0.07%
14,750
-810
-5% -$12K
XNCR icon
229
Xencor
XNCR
$1.48B
$214K 0.07%
9,740
-530
-5% -$11.5K
WBC
230
DELISTED
WABCO HOLDINGS INC.
WBC
$208K 0.07%
1,450
GHDX
231
DELISTED
Genomic Health, Inc.
GHDX
$205K 0.07%
5,990
-330
-5% -$10.5K
AKBA icon
232
Akebia Therapeutics
AKBA
$256M
$186K 0.06%
12,500
-15,270
-55% -$253K
CIVI
233
DELISTED
Civitas Solutions, Inc.
CIVI
$186K 0.06%
10,880
-620
-5% -$11.5K
AMAG
234
DELISTED
AMAG Pharmaceuticals
AMAG
$174K 0.06%
+13,110
New +$198K
CCXI
235
DELISTED
ChemoCentryx, Inc.
CCXI
$159K 0.05%
26,738
-1,250
-4% -$8.57K
CYTK icon
236
Cytokinetics
CYTK
$11B
$156K 0.05%
19,130
-1,070
-5% -$12.1K
INO icon
237
Inovio Pharmaceuticals
INO
$69.6M
$134K 0.04%
2,694
-149
-5% -$9.23K
ALE
238
DELISTED
Allete
ALE
-30,140
Closed -$2.33M
ASRT
239
DELISTED
Assertio
ASRT
-274
Closed -$95K
CADE
240
DELISTED
Cadence Bank
CADE
-67,371
Closed -$2.16M
CATY icon
241
Cathay General Bancorp
CATY
$4.26B
-58,930
Closed -$2.37M
CGNX icon
242
Cognex
CGNX
$11.2B
-8,260
Closed -$455K
CHRD icon
243
Chord Energy
CHRD
$7.46B
-214,690
Closed -$1.96M
CPS icon
244
Cooper-Standard Automotive
CPS
$491M
-26,730
Closed -$3.1M
DECK icon
245
Deckers Outdoor
DECK
$13.3B
-192,540
Closed -$2.19M
FSP
246
Franklin Street Properties
FSP
$47.1M
-213,150
Closed -$2.26M
GIFI
247
DELISTED
Gulf Island Fabrication
GIFI
-72,225
Closed -$917K
HELE icon
248
Helen of Troy
HELE
$671M
-9,900
Closed -$959K
HUBG icon
249
HUB Group
HUBG
$2.83B
-112,600
Closed -$2.42M
IWN icon
250
iShares Russell 2000 Value ETF
IWN
$14.5B
-2,000
Closed -$248K

Similar funds

Piermont Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Piermont Capital Management held 274 positions worth $305M, up 0.92% from $302M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Piermont Capital Management's Q4 2017 filing shows 32 new, 28 increased, 121 reduced and 37 closed positions. Its largest new stake was Brunswick: 53,300 shares worth $2.94M. The largest sale was LendingTree, an estimated $3.15M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Piermont Capital Management's largest Q4 2017 buy was Brunswick: 53,300 shares worth $2.94M.
  • Piermont Capital Management added most to Louisiana-Pacific in Q4 2017, an estimated $2.48M increase.
  • Piermont Capital Management's biggest Q4 2017 reduction was Spectrum Pharmaceuticals Inc, cutting an estimated $1.17M.
  • Piermont Capital Management fully exited LendingTree in Q4 2017, selling an estimated $3.15M.
  • Piermont Capital Management's ten largest holdings make up 11% of its $305M portfolio in Q4 2017.
  • Piermont Capital Management opened 32 new positions and closed 37 in Q4 2017.
  • Piermont Capital Management's portfolio value rose 0.92% quarter-over-quarter to $305M.

Based on Piermont Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.